Cortistatin protects against septic cardiomyopathy by inhibiting cardiomyocyte pyroptosis through the SSTR2-AMPK-NLRP3 pathway
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112186 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Fengqi Duan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Medicine, Sun Yat-sen University, Shenzhen, 518107, Guangdong, China; Department of Pathophysiology, Zhongsh…. Hauptthemen laut MEDLINE: Pyroptosis, Myocytes, Cardiac, Receptors, Somatostatin, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Although the pathophysiological mechanism of septic cardiomyopathy has been continuously discovered, it is still a lack of effective treatment method. Cortistatin (CST), a neuroendocrine polypeptide of the somatostatin family, has emerged as a novel cardiovascular-protective peptide, but the specific mechanism has not been elucidated. PURPOSE: The aim of our study is to explore the role of CST in cardiomyocytes pyroptosis and myocardial injury in sepsis and whether CST inhibits cardiomyocytes pyroptosis through specific binding with somastatin receptor 2 (SSTR2) and activating AMPK/Drp1 signaling pathway. METHODS AND RESULTS: In this study, plasma CST levels were significantly high and were negatively correlated with N-terminal pro-B type natriuretic peptide (NT-proBNP), a biomarker for cardiac dysfunction, in patients with sepsis. Exogenous administration of CST significantly improved survival rate and cardiac function in mouse models of sepsis by inhibiting the activation of the NLRP3 inflammasome and pyroptosis of cardiomyocytes (decreased cleavage of caspase-1, IL-1β and gasdermin D). Pharmacological inhibition and genetic ablation revealed that CST exerted anti-pyroptosis effects by specifically binding to somatostatin receptor subtype 2 (SSTR2), thus activating AMPK and inactivating Drp1 to inhibit mitochondrial fission in cardiomyocytes. CONCLUSIONS: This study is the first to report that CST attenuates septic cardiomyopathy by inhibiting cardiomyocyte pyroptosis through the SSTR2-AMPK-Drp1-NLRP3 pathway. Importantly, CST specifically binds to SSTR2, which promotes AMPK phosphorylation, inhibits Drp1-mediated mitochondrial fission, and reduces ROS levels, thereby inhibiting NLRP3 inflammasome activation-mediated pyroptosis and alleviating sepsis-induced myocardial injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, School of Medicine, Sun Yat-sen University, Shenzhen, 518107, Guangdong, China; Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guang…
- Department of Emergency Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510012, Guangdong, China.
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Duan, F., Li, L., Liu, S., Tao, J., Gu, Y., Li, H., Yi, X., Gong, J., You, D., Feng, Z., Yu, T., & Tan, H. (2024). Cortistatin protects against septic cardiomyopathy by inhibiting cardiomyocyte pyroptosis through the SSTR2-AMPK-NLRP3 pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112186
Vancouver
Duan F, Li L, Liu S, Tao J, Gu Y, Li H, et al. Cortistatin protects against septic cardiomyopathy by inhibiting cardiomyocyte pyroptosis through the SSTR2-AMPK-NLRP3 pathway. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112186
BibTeX
@article{Duan2024,
author = {Duan, Fengqi and Li, Li and Liu, Sijun and Tao, Jun and Gu, Yang and Li, Huangjing and Yi, Xiaoling and Gong, Jianfeng and You, Daiting and Feng, Zejiang and Yu, Tao and Tan, Hongmei},
title = {Cortistatin protects against septic cardiomyopathy by inhibiting cardiomyocyte pyroptosis through the SSTR2-AMPK-NLRP3 pathway},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112186}
}
EUVIMED